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Abstract
Background: The use of molecular methods to diagnose Clostridium difficile infection (CDI) has improved diagnostic yield
compared to conventional methods. However, PCR testing can detect colonization and has introduced several practical
challenges pertaining to need for treatment and isolation of cases.
Methods: For all new cases detected by real-time PCR, concurrent cytotoxin assay was performed and genetic
characterization with MLVA (multi-locus variable number tandem repeat analysis) was done to determine relatedness. We
used PCR cycle threshold (Ct) of detection as surrogate marker for bacterial burden in stool.
Results: Overall, 54 cases of CDI were detected during the study period. 42 were concurrently tested by CYT and
characterized by MLVA .MLVA analysis revealed marked genetic diversity with no ongoing outbreaks; four cases were due to
NAP1 strain. CYT 2/PCR + cases had a higher median Ct value of detection compared to CYT+/PCR + cases (28.2 vs 22.5;
p = 0.01). Among 25 strains that were genetically related, 9/11 isolates in this dominant cluster were positive by CYT
compared to 4/14 in non-dominant clusters (p = 0.02).
Conclusion: CYT2/PCR+ cases contribute to hospital based transmission. However, the risk of transmission of C. difficile
from CYT +/PCR+ cases may be higher than those that are CYT2/PCR+.
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Introduction
The introduction of molecular diagnostics into routine hospital
care has brought remarkable accuracy and speed into the
identification of numerous infections.
However, the increased sensitivity of molecular tests has
identified many patients, whose infection would have escaped
detection utilizing conventional methods, creating uncertainty
about when, and for how long to isolate. Of particular concern is
Clostridium difficile, the most common cause of hospital-acquired
diarrhea. At many facilities, the overall detection of C. difficile
associated diarrhea has increased by 50% or more due to
improved sensitivity and favorable operation characteristics of
the molecular test [1–3]. Yet the contagiousness of patients who
are positive on molecular tests but negative by conventional
methods is not known.
Recent epidemiologic studies based on CDI cases detected by
Enzyme immunoassay (EIA) and culture positive samples have
shown that approximately 25% of all CDI cases can be attributed
to ward based transmission [4]. Whether additional cases that are
detected by molecular methods (PCR) only contribute to hospital
based transmission and has thus far been the undetected reservoir
of infection, has never been formally studied. To examine this, we
compared cases of C. difficile infection detected by PCR only (CYT
negative) with cases detected both CYT and PCR in a
hyperendemic pediatric population. We based assessment of
transmission potential on bacterial carriage and genetic relatedness
using the following,
1. Threshold cycle of detection as a surrogate marker for bacterial
load and in turn greater risk of environmental contamination
and;
2. Genetic relatedness using a highly discriminatory MLVA
(multi-locus variable number tandem repeat analysis).
Methods
Memorial Sloan Kettering Cancer Center (MSKCC) is a 470-
bed tertiary care hospital in New York City with a 39 bed
inpatient pediatric unit. Each year, there are approximately 1,500
pediatric admissions and 11,000 pediatric patient days annually.
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The average length of stay for pediatrics is 7.4 days. The pediatric
day hospital (PDH) is a 36 bed facility for outpatient chemother-
apy administration and outpatient evaluation and management
with about 100 visits per day. Samples were collected from
September 2010 until March 2011.
Laboratory methods
All stool samples obtained from pediatric patients that tested
positive for C.difficile were stored at 280uC within 24 hours of
receipt in the lab. Patients with recurrent CDI or with duplicate
specimens obtained within two weeks were excluded from the
study.
Xpert C. difficile PCR. The assay was approved by the Food
and Drug Administration (FDA) for the detection of C. difficile
directly from stool specimens. The assay detects the toxin B gene
within 1 hour with minimal hands-on time based on real-time
PCR (Cepheid, Sunnyvale, CA). The Xpert C. difficile PCR
(Xpert PCR) was performed according to the manufacturer’s
instructions and as previously described [5]. The cycle threshold
(Ct) was defined as the number of PCR cycle required to generate
a fluorescent signal above the background fluorescence [6]. It is a
relative measure of the concentration of target gene in the PCR
reaction.
Cytotoxin neutralization assay (CYT). The CYT assay
was performed as previously described. The assay detects the
presence of the toxin B protein as measured through the presence
of cytopathic effect in commercially available human lung
fibroblast cell line (Diagnostics Hybrids, Athens, OH) [5].
C. difficile culture. C. difficile selective agar (CDSA; BD
BBL, Sparks, MD) plates were reduced overnight in an anaerobic
chamber prior to use. Stool sample was added to 500 ml of 100%
ethanol, vortexed, and incubated at room temperature for 1 to
2 h. The solution was centrifuged at 1,2006 g for 5 min, ethanol
was removed, and the stool sample was inoculated onto reduced
CDSA plates. The plates were incubated for 48 h under anaerobic
conditions. Colonies resembling C. difficile (pale yellow to yellow)
were sub cultured on sheep blood agar (SBA) plates, and their
identity was further confirmed by Remel PRO disk (Thermo
Fischer Scientific, Waltham, MA).
MLVA
MLVA and tcdC sequencing were performed as previously
described [7]. Resulting tcdC sequences were assigned genotypes
by querying the PubMLST database (http://www.pubmlst.org/
cdifficile). Minimum spanning trees of the MLVA data were
generated using BioNumerics software v6.6 (Applied Maths,
Austin TX). The summed tandem repeat difference (STRD) was
used as coefficient for determining genetic distance. Based on
validation studies performed in an outbreak setting comparing
MLVA to REA (restriction enzyme analysis) and whole genome
sequencing (WGS) [8] [9], STRD genetic relationships were
defined as follows-
Outbreak. Strains with STRD#2 are considered highly
related and representative of an outbreak [9].
Genetically related. Isolates with genotypes having STRD
greater than 2 but #10 are considered genetically related but not
part of an outbreak [8,9].
Clinical data
C. difficile cases were defined by positive test (PCR or CYT
assay). A retrospective chart review was conducted for all patients
with positive specimens; clinical, laboratory and demographic data
were extracted from the electronic MSKCC clinical information
system. Demographic data included age and sex. Clinical data
included underlying cancer, transplant type, inpatient stay and
duration, presence or absence of diarrhea, previous CDI, and,
when applicable, time to recurrence. Cases were defined as
healthcare -associated (HA) or community acquired (CA) based on
interval between admission and positive test result for CDI. An
interval of $72 hours after admission was used to define HA cases
of CDI. The MSKCC Internal Review Board reviewed the study
and granted a HIPAA waiver of authorization.
Statistical analysis
Statistical significance testing was performed using chi-squared
tests of independence for categorical variables. The Student’s t-test
was used for mean age, assuming equal variances. The Wilcoxon
Rank Sum test was used for median age.
Results
A total of 54 new C. difficile cases occurred during the study
period (September 2010 until March, 2011). Forty-seven samples
were available for MLVA typing C. difficile could not be cultured
from 5 frozen stool samples, 2 samples were lost during storage.
Due to limited sample availability, 42/47 samples that were
characterized by MLVA could be concurrently tested with CYT.
These 42 samples were included in the final analysis.
For the 42 patients, the median age of the cohort was 11.2
years. 4/42 children were #2 years of age, 50% were females.
Eighteen patients were allogeneic hematopoietic stem cell trans-
plant (HSCT) recipients. Four patients had underlying ALL and
five had neuroblastoma. 19/42 cases were healthcare associated
and 38/42 (91%) of patients had diarrhea recorded at the time of
testing. In three of the remaining four patients, the presence of
diarrhea or change on bowel pattern could not be definitely
ascertained due to presence of fecal incontinence, acute lower GI
bleeding and chronic lower gastrointestinal GVHD. In one
patient, testing was done for fever and abdominal pain that
developed during stem cell infusion.
MLVA and tcdC typing
The results of MLVA typing of the study cohort are shown in
Figure 1 along with results of CYT testing. For 42 isolates that
were tested by CYT and characterized by MLVA, 23 were
positive by CYT and 25 were genetically related. Among the 25
strains that were genetically related, 13 were positive by CYT
compared to 10/17 strains that were unrelated (p= 0.3).One
dominant cluster accounted for almost half of all the related strains
(n = 11); isolates within this cluster are related by MLVA but are
not part of an outbreak (8). Rather, the strain corresponds to
common genetic lineages as defined by tcdC genotyping and
represent endemic disease in the hospital setting. 9/11 isolates in
this dominant cluster were positive by CYT compared to 4/14 in
non-dominant clusters (p = 0.01).
The tcdC-1 genotype (corresponding to Ribo type 027) was
detected in four samples and was the third most common tcdC
genotype isolated among our cohort. Isolates bearing the tcdC-19
genotype were the most common (32%) followed by tcdC-9
genotype which was also highly prevalent (21%).
Testing of PCR positive samples by CYT
Among 42 samples on which CYT was performed, 23 were
found to be positive by CYT. For samples included in the present
study on which both CYT and PCR were performed, we found
that CYT 2/PCR + cases had a higher median Ct value of
detection compared to CYT+/PCR + cases (28.2 vs 22.5; p = 0.01;
95%CI 0.85 to 6.8) [Figure 2].
Epidemiology of C. difficile Cases Detected by PCR
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Discussion
The introduction of highly sensitive diagnostic tests has led to
identification of additional cases of many diseases with the
potential for hospital transmission. This in turn has led to a need
to estimate the relative contagiousness of the additional cases
detected only by molecular methods. To explore this, we
examined the relationship between detection method and genetic
relatedness as determined by MLVA in a group of C.difficile isolates
collected over a six month period in a closed population of
children with cancer.
We found a significant relationship between low Ct value and
concurrent positivity on cytotoxin assay. However, we did not
detect any difference in genetic relatedness of isolates detected by
the different testing methods. The only striking finding is the
concomitant positivity on CYT among majority (9/11) of isolates
belonging to the dominant endemic strain in the cohort. Our
findings establish that cases detected by PCR only contribute
towards hospital based transmission. However, dominant endemic
clones are likely to be CYT positive, whether this is related to
higher bacterial load or strain characteristics, needs to be
addressed in future studies.
Children with cancer are a particularly suitable group for
examination of the transmission dynamics of CDI. Similar to
adults, cancer poses a substantial risk for CDI in children. The rate
of CDI is sixteen times higher in children with cancer than other
hospitalized children; children at highest risk include those with
hematological cancer or those undergoing hematopoietic stem cell
transplant [10,11].Secondly, children with cancer may have
diarrhea for multiple reasons and diagnostic tests that detect toxin
gene (PCR) rather than toxin itself may detect colonization. For
many years, testing and treating infants and children for CDI was
discouraged because of recognition that asymptomatic coloniza-
tion was common [12–16]. However, the appearance of the hyper
virulent NAP1 strain among older children in the community led
to a new appreciation of the potential role of this organism in the
young, as did reports of its role as a pathogen among children with
cancer and other chronic medical conditions. As a result, over the
last decade there has been a renewed interest in examining the
epidemiology of C. difficile in healthy and hospitalized children
[14,17–19].
At the same time as the apparent shift in epidemiology of CDI
[20–22], PCR based detection of C. difficile has increasingly been
adopted for diagnosis. The implementation of this technology
carries uncertainty due to potential over-detection since the test
cannot distinguish between colonization and true disease. Many
centers find that PCR increases the detection of C. difficile by up to
two fold and the incremental cases detected by PCR only, often
are clinically mild [2]. Recent study by Curry et al examines
transmission pattern from hospitalized patients with asymptomatic
C. difficile colonization compared to those with CDI(using found
specimens submitted for screening of VRE), their findings
attributed 30% of incident cases to CDI patients, whereas 29%
Figure 1. Minimum spanning tree of MLVA data from study isolates (n=47). Letter symbol in the center of the circle represents the results
for testing by cytotoxin assay for 42 samples included in the analysis (C + and C2). Five samples were not tested by CYT (NT). Each circle represents a
distinct MLVA type and numbers between the circles represent the STRD [Summed tandem repeat difference]. Isolates with a STRD,10 are
highlighted in colored clouds representing clusters (genetically related clonal complexes). tcdC sequencing is depicted by color coding within circles
with tcdC 1 (corresponding to NAP1) strain represented in red (reference in right corner).
doi:10.1371/journal.pone.0088262.g001
Figure 2. PCR threshold cycle value (Ct) for forty-two samples
tested by Cytotoxin assay (CYT) and PCR.
doi:10.1371/journal.pone.0088262.g002
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cases were associated with carriers. Although PCR was not used
for screening, this study highlights the role of asymptomatic
colonization with C. difficile in hospital based transmission [23].
Our data in a closed population of children with cancer
supports that incremental new cases detected by real-time PCR
are genetically related to endemic strains and likely contribute
towards previously undetected transmission; however most cases
caused by the dominant endemic strain in our cohort were
detected using conventional methods. Our study has several
limitations; we were unable to retrieve seven samples in the cohort
and therefore may have missed an outbreak, although this seems
unlikely as the cases were spread out in time and space. We had
very few patients less than 24 months old [seven patients] and are
unable to draw any meaningful conclusions about strain preva-
lence and CDI related outcomes in this group of infants. We used
a highly discriminatory typing method- although our results were
objective, unambiguous and reproducible, comparisons with other
studies that have used a wide variety of molecular typing methods,
had to made indirectly by correlation with REA, PCR ribotypes
and tcdC genotypes. We do not think this limit the findings of our
study as establishment of such genetic relationships has been
corroborated by other studies [7,24].Also, Xpert C. difficile assay is
only FDA approved as a qualitative assay, its use as a semi-
quantitative assay will need further validation. Ct values were
derived from stool samples- volume loaded on swabs may have
had an impact on the results, although processing of samples is
done following standard protocol and our findings support that
such bias is unlikely to have influenced the typing results. Finally,
the epidemiology of CDI may be different in pediatric patients
with cancer as compared to other hospitalized children due to
frequent healthcare related exposure, underlying immunosuppres-
sion and greater antibiotic use.
In summary, in a closed population of children with cancer, we
have found that additional C. difficile cases detected by PCR only
are genetically related to endemic strains in the hospital and
represent previously undetected transmission, although the dom-
inant endemic clones are likely to be positive when tested using
conventional methods.
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